- Filed
- Apr 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 10, 2026 | 33.1M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 33.24M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 33.03M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 32.92M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 32.89M sh |
| Dividends Paid | Q2 2026 · Oct 31, 2025 | $3.01M |
| Dividends Paid | Q2 2026 · Oct 31, 2024 | $3.04M |
| Capex | Q2 2026 · Oct 31, 2025 | $8.05M |
| Capex | Q2 2026 · Oct 31, 2024 | $5.59M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2025 | $8.98M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2024 | −$63.98M |
| Short Term Investments | Q2 2026 · Oct 31, 2025 | $59.76M |
| Short Term Investments | Q2 2026 · Apr 30, 2025 | $88.79M |
| Cash And Equivalents | Q2 2026 · Oct 31, 2025 | $126.92M |
| Cash And Equivalents | Q2 2026 · Oct 31, 2024 | $80.54M |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $306.94M |
| Stockholders Equity | Q2 2026 · Apr 30, 2025 | $298.13M |
| Current Liabilities | Q2 2026 · Oct 31, 2025 | $495.71M |
| Current Liabilities | Q2 2026 · Apr 30, 2025 | $265.88M |
| Total Liabilities | Q2 2026 · Oct 31, 2025 | $803.24M |
| Total Liabilities | Q2 2026 · Apr 30, 2025 | $543.58M |
| Current Assets | Q2 2026 · Oct 31, 2025 | $934.24M |
| Current Assets | Q2 2026 · Apr 30, 2025 | $631.82M |
| Total Assets | Q2 2026 · Oct 31, 2025 | $1.38B |
| Total Assets | Q2 2026 · Apr 30, 2025 | $1.1B |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | $0.36 |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | $0.33 |
| Eps Diluted restated | Q2 2026 · Oct 31, 2024 | $0.93 |
| Eps Diluted restated | Q2 2026 · Oct 31, 2024 | $1.77 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | $0.37 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | $0.34 |
| Eps Basic restated | Q2 2026 · Oct 31, 2024 | $0.95 |
| Eps Basic restated | Q2 2026 · Oct 31, 2024 | $1.81 |
| Net Income | Q2 2026 · Oct 31, 2025 | $11.99M |
| Net Income | Q2 2026 · Oct 31, 2025 | $11.06M |
| Net Income restated | Q2 2026 · Oct 31, 2024 | $30.8M |
| Net Income restated | Q2 2026 · Oct 31, 2024 | $57.88M |
| Operating Income | Q2 2026 · Oct 31, 2025 | $40.06M |
| Operating Income | Q2 2026 · Oct 31, 2025 | $13.7M |
| Operating Income restated | Q2 2026 · Oct 31, 2024 | $70.43M |
| Operating Income restated | Q2 2026 · Oct 31, 2024 | $83.99M |
| Revenue | Q2 2026 · Oct 31, 2025 | $650.17M |
| Revenue | Q2 2026 · Oct 31, 2025 | $942.21M |
| Revenue | Q2 2026 · Oct 31, 2024 | $616.25M |
| Revenue | Q2 2026 · Oct 31, 2024 | $799.74M |